Global Kidney/Renal Function Test Market, By Product Type (Dipsticks, Reagents, Disposables), Test Type (Urine Tests, Blood Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, Others) – Industry Trends and Forecast to 2030.
Kidney/Renal Function Test Market Analysis and Size
According to the CDC reports, more than 37 million people in the U.S. are expected to suffer from CKD, while globally, more than 500 million people are affected. Also, lifestyle diseases and kidney injuries are major risk factors for CKD. Additionally, the growing adoption of digital urinalysis indicates the increasing demand for home diagnostics of renal or kidney diseases, driving the market growth.
Data Bridge Market Research analyses a growth rate in the kidney/renal function test market in the forecast period 2023-2030. The expected CAGR of the kidney/renal function test market tends to be around 6.20 % in the mentioned forecast period. The market was valued at USD 874.7 million in 2022 and would grow to USD 1415.31 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Kidney/Renal Function Test Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Dipsticks, Reagents, Disposables), Test Type (Urine Tests, Blood Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Danaher. (U.S.), bioMérieux (France), Siemens Healthcare Private Limited (Germany), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), Nova Biomedical (U.S.), Trinity Biotech (Ireland), Alfa Scientific Designs, Inc (U.S.), IDEXX (U.S.), Beckman Coulter, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
The kidney/renal function tests are used to diagnose any defect in the functions of the kidney. The common symptoms of these diseases are difficulty in urination due to increased body fluids, blood in urine, swelling in hands or feet, and swollen face. Kidney or Renal diseases may develop over the years, leading to end-stage kidney (or renal) disease (ESRD). It has become a massive public health issue. For the correct identification of these diseases, they are used widely.
Global Kidney/Renal Function Test Market Dynamics
Drivers
- Increased Prevalence of Kidney Diseases
The growing incidence of chronic kidney disease worldwide is majorly responsible for enhancing the market's growth. As per the National Kidney Foundation records, approximately 10% of the global population is affected by chronic kidney disease (CKD). According to WHO facts 2019, around 1.13 billion people globally have hypertension. In 2014–2016, diabetes and hypertension were responsible for about 75% of kidney failure. This increasing prevalence demands higher demand for tests for early disease detection, leading to market growth. Thus, it boosts the market growth.
- Increasing Technological Advancements by Market Players
The increased adoption of digital urinalysis specifies the increasing demand for home diagnostics, enhancing market growth. For instance, Healthy.io, a start-up in digital health headquartered in Israel, developed an FDA-cleared at-home smartphone urinalysis test to assist people in opting for kidney tests for proteins. Early detection helps to prevent complications from kidney diseases. Furthermore, the company's urinalysis test, called Dip.io, uses disposable cups and strips in combination with a smartphone camera to interpret and read the results. Thus, this factor boosts market growth.
Opportunities
- Growing Demand for Hospitals
The wide presence of many hospitals in the U.S. and a well-developed healthcare infrastructure are other major factors leading to market growth. For instance, according to the American Hospital Association, there were about 208 federal government hospitals, 6,090 community hospitals, and 625 non-federal psychiatric hospitals in the U.S. Also, a major increase in hospital admissions for acute kidney disease is enhancing the demand for dialysis and transplant, boosting the market growth.
- Rising Strategic Agreements by Organizations
The top manufacturers in the region are primarily focused on developing innovative products. For instance, Abbott HealthTab, Inc. signed a non-assignable pilot supplier distribution agreement with Abbott for i-STAT Alinity, a handheld blood chemistry analyzer, in 2021. The agreement allows HealthTab to deliver Abbott's POC i-STAT Alinity and its associated tests for creatinine in Canadian drug stores to help patients receive necessary information about their kidney functions. Thus, this factor boosts market growth.
Restraints/Challenges
- Side Effects of Kidney/Renal Disease Drugs
The side effects associated with these renal drugs could decrease the growth of the global market over a forecast period. Effects such as loss of appetite, fever, and rashes can hamper the market growth. Other rare, more severe side effects involve decreased blood cell numbers and liver and kidney problems observed by changes in the blood tests. Thus, these factors lead to market hindrances.
This global kidney/renal function test market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global kidney/renal function test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Kidney/ Renal Function Test Market Scope
The global kidney/renal function test market is segmented on the basis of product type, test type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Dipsticks
- Reagents
- Disposables
Test Type
- Urine Tests
- Blood Tests
End User
- Hospitals, Diagnostic Laboratories
- Research Laboratories and Institutes
- Others
Kidney/ Renal Function Test Market Regional Analysis/Insights
The kidney/renal function test market is analyzed and market size insights and trends are provided by product type, test type and end user as referenced above.
The major countries covered in the kidney/renal function test market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominated the market growth for the kidney/renal function test market throughout the forecasted period to the huge presence of supportive government initiatives and the persistent implementation by healthcare organizations within the region.
Asia-Pacific is expecting high market growth due to government and pharmaceutical organizations' growing initiatives to raise awareness and the wide presence of generic manufacturers. Also, the rapid increase in R&D investment by the market players leads to market growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Kidney/ Renal Function Test Market Share Analysis
The global kidney/renal function test market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global kidney/renal function test market
Key players operating in the kidney/renal function test market include:
- Pfizer Inc (U.S.)
- AstraZeneca (U.K.),
- Bristol-Myers Squibb Company (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Abbott (U.S.)
- Danaher. (U.S.)
- bioMérieux (France)
- Siemens Healthcare Private Limited (Germany)
- BD (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Sysmex Corporation (Japan)
- Nova Biomedical (U.S.)
- Trinity Biotech (Ireland)
- Alfa Scientific Designs, Inc (U.S.)
- IDEXX (U.S.)
- Beckman Coulter, Inc. (U.S.)
SKU-